Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT

Spruce Biosciences Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Spruce Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $147.88. The average 1-year stock price forecast is 133.25% higher than the current stock price, while the lowest is $104 (+64.04%) and the highest is $230 (+262.78%).

Price Target: $147.88 (+133.25%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$104$147.88$142$230
Change+64.04%+133.25%+123.97%+262.78%

Analyst Ratings

The average analyst rating for Spruce Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy344677
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total455788

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Reiterates
$230
BuyReiterates$230+262.78%Aug 25, 2026
Guggenheim
Guggenheim
Buy
Maintains
$123$104
BuyMaintains$123$104+64.04%Aug 17, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$140
BuyMaintains$140+120.82%Aug 13, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$160
BuyInitiates$160+152.37%Jul 13, 2026
JonesTrading
JonesTrading
Buy
Initiates
$135
BuyInitiates$135+112.93%Jun 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
88.56M
EPS This Year
-27.16
from -50.83
EPS Next Year
8.09
from -27.16
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--10.09M4.91M--
Gross Profit
--35.20M-39.34M-41.51M-13.62M-
Gross Margin
---389.96%-845.18%-90.00%
Operating Income
-42.07M-47.28M-51.99M-56.15M-28.61M-60.15M
Net Income
-42.29M-46.18M-47.92M-53.04M-38.97M-60.10M
EPS
-----50.83-27.16
Free Cash Flow
-20.70M-25.55M-17.52M-38.75M-16.67M-56.50M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-24.61
Avg-27.16
Low-32.69

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-